The direct costs of cancer in Europe( costs of treating cancer patients) seems to have peaked past decade in PPP terms, despite rising cancer cases due to population aging
Posted by Straight_Ad2258
The direct costs of cancer in Europe( costs of treating cancer patients) seems to have peaked past decade in PPP terms, despite rising cancer cases due to population aging
Posted by Straight_Ad2258
2 Comments
source: [https://www.efpia.eu/media/nbbbsbhp/ihe-comparator-report-on-cancer-in-europe-2025.pdf](https://www.efpia.eu/media/nbbbsbhp/ihe-comparator-report-on-cancer-in-europe-2025.pdf) page 50
one of the main drivers of cost stagnation is the expiration of patents for blockbuster drugs
almost 22 billion euros have been saved in Europe cumulatively just by the expiration of these 5 cancer drug patents past years
https://preview.redd.it/sac3xnonqkjf1.jpeg?width=890&format=pjpg&auto=webp&s=8e74af49f6077cf726fb0d4cf9bfa664e0d2988a
page 167 [https://www.efpia.eu/media/nbbbsbhp/ihe-comparator-report-on-cancer-in-europe-2025.pdf](https://www.efpia.eu/media/nbbbsbhp/ihe-comparator-report-on-cancer-in-europe-2025.pdf)
looking forward to see immunotherapy drugs patents expire en masse in coming years, especially Keytruda, which is now approved for over 40 cancer types